|
|
| CrossRef Text and Data Mining | |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
| Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease | |
| Hyun Gyung Lee, Eun Mi Yang, Chan Jong Kim | |
|
Ann Pediatr Endocrinol Metab. 2021;26(3):199-204. Published online September 30, 2021 DOI: https://doi.org/10.6065/apem.2142046.023 |
|
|
Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease Annals of Pediatric Endocrinology & Metabolism. 2021;26(3):199-204  Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism Thyroid. 2015;25(1):43-50 Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital Jakarta International Journal of Pediatric Endocrinology. 2013;2013(S1): Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study Clinical Endocrinology. 1998;49(4):451-457 Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease Journal of the Endocrine Society. 2021;5(4): Neuroendocrine-Related Adverse Events Associated with Antidepressant Treatment in Children and Adolescents CNS Neuroscience & Therapeutics. 2010;16(2):83-90 Immune-related and adverse events following low versus high initial dose of Viscum album L. in cancer patients Annals of Oncology. 2016;27:vi515 Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report Journal of Medical Case Reports. 2021;15(1): Methimazole-Induced Agranulocytosis in Patients with Graves' Disease Is More Frequent with an Initial Dose of 30 mg Daily than with 15 mg Daily Thyroid. 2009;19(6):559-563 Long-Term, Low-Dose Methimazole Therapy Is Effective in Protecting against Relapses in Graves’ Disease Clinical Thyroidology. 2023;35(02):54-56 |
